PRTA · Prothena Corp Public Ltd Co · Metrics
$8.34
-0.02 (-0.18%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q4 2025 earnings call transcript
Market Cap
$428.77M
Shares
51.35M
Volume · Nov 19
130.48K
Avg daily vol (3M)
475.61K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
PRTA metrics
74 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$8.35
Market cap
$428.77M
Price action
23 metricsPrice change (1W)
-4.4%
Price change (30D)
-1.5%
Price change (3M)
-10.1%
Price change (6M)
-10.7%
Price change (YTD)
-12.6%
Price change (1Y)
-19.4%
Trailing year
Price change (5Y)
-84.7%
52-week high
$11.51
52-week low
$7.89
Change from 52-week high
-27.5%
Change from 52-week low
+5.8%
Annualized volatility
48.8%
Annualized volatility (3M)
52.2%
Implied volatility (30D)
64.0%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.1
RSI (14D)
49.3
Price vs SMA 50
-1.3%
Price vs SMA 200
-8.9%
Avg volume (3M)
475,604
Relative volume
1.6
Average dollar volume
$4.11M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
51.35M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
8.1×
reciprocal yield 12.3%
P / book
1.6
reciprocal yield 62.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-5.6%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-02-19
Profitability
9 metricsGross margin
—
Operating margin
-64.6%
Trailing 12 months
Net margin
-45.4%
Gross profit (TTM)
—
Operating profit (TTM)
−$34.09M
Net income (TTM)
−$23.96M
Trailing 12 months
Diluted EPS (TTM)
$-0.47
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-74.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$52.73M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-4.4%
Year over year · fewer shares
Revenue CAGR (3Y)
-43.6%
Revenue CAGR (5Y)
+62.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-8.9%
Return on assets
-8.5%
Debt / equity
—
Current ratio
24.0
EBITDA (TTM)
−$33.28M
Free cash flow (TTM)
—
Quick ratio
24.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$271.37M
Latest balance sheet
Cash & equivalents
$271.37M
Total assets
$283.52M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$31.45M
Capital expenditures (TTM)
—
R&D (TTM)
$44.44M
SG&A (TTM)
—
Stock compensation (TTM)
$28.27M
R&D / revenue
84.3%
Stock compensation / revenue
53.6%
Ownership (13F)
9 metrics13F filers
182
13F filer change QoQ
-7
Institutional ownership
90.1%
Conviction holders (share of 13F filers)
1.1%
Crowding (high-turnover and private-fund holders)
35.7%
Private-fund adviser ownership
32.6%
Active holders' share change QoQ
-0.9%
Holder tenure
14.3
Price vs estimated holder cost
-14.4%
Ownership (registered funds)
1 metricsIndex-fund ownership
2.2%
Short interest
3 metricsShort interest
15.4%
Latest settlement · 15.7 days to cover
Days to cover
15.7d
Short-squeeze score
74 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1559053
CUSIP
G72800108
13F (30d)
201 filings
173 filers
Visit website
Investor relations